. Myelitis as a side effect of tofersen therapy in SOD1-associated ALS. J Neurol. 2024 Apr;271(4):2114-2118. Epub 2023 Dec 9 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. QALSODY™